Circulating nucleic acids (CNAs) and cancer--a survey
- PMID: 17137717
- DOI: 10.1016/j.bbcan.2006.10.001
Circulating nucleic acids (CNAs) and cancer--a survey
Abstract
It has been known for decades that it is possible to detect small amounts of extracellular nucleic acids in plasma and serum of healthy and diseased human beings. The unequivocal proof that part of these circulating nucleic acids (CNAs) is of tumor origin, initiated a surge of studies which confirmed and extended the original observations. In the past few years many experiments showed that tumor-associated alterations can be detected at the DNA and RNA level. At the DNA level the detection of point mutations, microsatellite alterations, chromosomal alterations, i.e. inversion and deletion, and hypermethylation of promoter sequences were demonstrated. At the RNA level the overexpression of tumor-associated genes was shown. These observations laid the foundation for the development of assays for an early detection of cancer as well as for other clinical means.
Similar articles
-
Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?Int J Cancer. 2003 Jan 10;103(2):149-52. doi: 10.1002/ijc.10791. Int J Cancer. 2003. PMID: 12455027 Review. No abstract available.
-
Circulating nucleic acids as a tumor marker.Histol Histopathol. 2002;17(3):937-43. doi: 10.14670/HH-17.937. Histol Histopathol. 2002. PMID: 12168805 Review.
-
Plasma nucleic acids in the diagnosis and management of malignant disease.Clin Chem. 2002 Aug;48(8):1186-93. Clin Chem. 2002. PMID: 12142371 Review.
-
Circulating DNA in plasma or serum.Medicina (B Aires). 2000;60(5 Pt 2):699-702. Medicina (B Aires). 2000. PMID: 11188885 Review.
-
Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.J Mol Diagn. 2015 May;17(3):209-24. doi: 10.1016/j.jmoldx.2015.02.001. J Mol Diagn. 2015. PMID: 25908243 Free PMC article. Review.
Cited by
-
Diagnostic accuracy of ESR1 mutation detection by cell-free DNA in breast cancer: a systematic review and meta-analysis of diagnostic test accuracy.BMC Cancer. 2024 Jul 28;24(1):908. doi: 10.1186/s12885-024-12674-z. BMC Cancer. 2024. PMID: 39069608 Free PMC article.
-
Transcriptome analysis and molecular characterization of novel small RNAs in Mycobacterium tuberculosis Lineage 1.World J Microbiol Biotechnol. 2024 Jul 25;40(9):279. doi: 10.1007/s11274-024-04089-6. World J Microbiol Biotechnol. 2024. PMID: 39048776
-
Liquid biopsy for gastric cancer: Techniques, applications, and future directions.World J Gastroenterol. 2024 Mar 28;30(12):1680-1705. doi: 10.3748/wjg.v30.i12.1680. World J Gastroenterol. 2024. PMID: 38617733 Free PMC article. Review.
-
DNA corona on nanoparticles leads to an enhanced immunostimulatory effect with implications for autoimmune diseases.Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2319634121. doi: 10.1073/pnas.2319634121. Epub 2024 Mar 5. Proc Natl Acad Sci U S A. 2024. PMID: 38442162 Free PMC article.
-
ACEK Biosensor for the Minute-Scale Quantification of Breast Cancer ctDNA.Sensors (Basel). 2024 Jan 15;24(2):547. doi: 10.3390/s24020547. Sensors (Basel). 2024. PMID: 38257640 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous